亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

湖北遠(yuǎn)成藥業(yè)有限公司(武漢)  

精細(xì)化工,香精香料,食品添加劑,醫(yī)藥原料及中間體等產(chǎn)品

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:顧亞男
  • 電話:027-50756114
  • 郵件:ycmanagers06@ycphar.com
  • 傳真:027-88048077
  • QQ:2355327070
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 美羅培南混粉
美羅培南混粉
單價 面議對比
詢價 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫存 5000KG起訂1KG
品牌 南箭
過期 長期有效
更新 2015-03-13 09:11
 
詳細(xì)信息

美羅培南混粉 
英文名:Meropenem for injection/meropenem with sodium carbonate
Cas: 119478-56-7
物理性質(zhì):美羅培南和碳酸鈉混粉,外觀為白色或類白色結(jié)晶性粉末
質(zhì)量標(biāo)準(zhǔn):USP34,無菌
含量:78% 添加了碳酸鈉
丙酮 禁發(fā)殘留<500ppm,
包裝:1KG 鋁箔袋
用途:抗生素類抗感染原料藥
©2025 湖北遠(yuǎn)成藥業(yè)有限公司(武漢) 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:20266  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |